WHO SMART Guidelines - HIV
0.3.0 - ci-build

WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Codings

Note that the terminologies included in this implementation guide will need to be updated, because the ideal mechanism for distribution (as an expression) is not currently supported by the content logical definition constructs available in the FHIR ValueSet resource and all known implementations of it. Before use in a production environment, ensure you have the latest value sets based on the definitions for each value set (as defined in the inclusion/exclusion criteria for each one).

The following terminology artifacts are included for this implementation guide:

CodeSystems

  • WHO SMART HIV Concepts CodeSystem

    • ValueSets

  • Country of birth ValueSet
  • Gender ValueSet
  • Sex ValueSet
  • Marital Status ValueSet
  • Administrative Area ValueSet
  • Communication preference(s) ValueSet
  • Referred by ValueSet
  • Reason for visit ValueSet
  • Test result of HIV assay 3 ValueSet
  • Test result of HIV assay 1 repeated ValueSet
  • HIV test result ValueSet
  • HIV status ValueSet
  • Site where positive HIV test confirmed ValueSet
  • Probable route of transmission ValueSet
  • Partner HIV test result ValueSet
  • Partner HIV status (confirmed) ValueSet
  • Counselling provided ValueSet
  • Prevention services offered and referrals ValueSet
  • Testing entry point ValueSet
  • Sexual and reproductive health integrated services ValueSet
  • Offer other clinical services ValueSet
  • Other support services ValueSet
  • Intimate partner violence enquiry results ValueSet
  • Entry point for community-level testing ValueSet
  • Type of follow-up appointment ValueSet
  • Adverse event severity ValueSet
  • Timing of adverse event ValueSet
  • Type of adverse VMMC event ValueSet
  • Entry point for facility-level testing ValueSet
  • Syndrome/STI diagnosed ValueSet
  • STI tested for ValueSet
  • Syphilis test result ValueSet
  • Gonorrhoea test result ValueSet
  • Type of specimen ValueSet
  • Syphilis test type ValueSet
  • Neisseria gonorrhoeae test type ValueSet
  • Chlamydia trachomatis test type ValueSet
  • Trichomonas vaginalis test type ValueSet
  • Herpes simplex virus (HSV) test type ValueSet
  • Mycoplasma genitalium test type ValueSet
  • STI test result ValueSet
  • Confirmatory syphilis test type ValueSet
  • Confirmatory STI test result ValueSet
  • Partner HIV status (reported) ValueSet
  • Partner is from a key population ValueSet
  • HIV self-test result ValueSet
  • Referred through partner services ValueSet
  • Key population member type ValueSet
  • HIV exposure type ValueSet
  • HIV diagnosing facility ValueSet
  • HIV serotype ValueSet
  • Type of contact elicited ValueSet
  • Type of contact or partner for partner services ValueSet
  • HIV test type ValueSet
  • Assay number in testing strategy ValueSet
  • Test result of HIV assay 1 ValueSet
  • Test result of HIV assay 2 ValueSet
  • Reason for PrEP visit ValueSet
  • Alternative third PEP drug ValueSet
  • Sex factor for estimating creatinine clearance ValueSet
  • PrEP dosing type ValueSet
  • Contraindications to PrEP usage ValueSet
  • PrEP regimen prescribed ValueSet
  • Type of follow-up appointment ValueSet
  • Prevention services offered and referrals ValueSet
  • Condom type ValueSet
  • HIV self-test distributed for use by ValueSet
  • Sexual and reproductive health integrated services ValueSet
  • Offer other clinical services ValueSet
  • Other support services ValueSet
  • Current PrEP regimen ValueSet
  • Experience with PrEP ValueSet
  • PEP history ValueSet
  • Signs of substantial risk of HIV infection ValueSet
  • Pregnancy intention in serodiscordant partnerships ValueSet
  • Acute HIV infection symptoms ValueSet
  • Sex partner's HIV treatment status ValueSet
  • Screenings and diagnostics for PrEP users ValueSet
  • Medications prescribed ValueSet
  • PrEP product prescribed ValueSet
  • Preferred PEP backbone regimen ValueSet
  • Alternative PEP backbone regimen ValueSet
  • Preferred third PEP drug ValueSet
  • HIV burden of the setting ValueSet
  • Other priority populations ValueSet
  • Reason for visit ValueSet
  • TB treatment outcome ValueSet
  • TB treatment regimen composition ValueSet
  • TB status at ART start ValueSet
  • TPT regimen type ValueSet
  • TB preventive treatment (TPT) status ValueSet
  • ART regimen composition ValueSet
  • ART regimen drug class ValueSet
  • Prevention services offered and referrals ValueSet
  • Sexual and reproductive health integrated services ValueSet
  • HBsAg test result ValueSet
  • HBV treatment regimen prescribed ValueSet
  • Signs of serious illness ValueSet
  • HCV test result ValueSet
  • HCV treatment regimen prescribed ValueSet
  • HCV viral load test result ValueSet
  • HCV medicine type ValueSet
  • HIV clinical stage ValueSet
  • Reason(s) for adherence problem ValueSet
  • Reason ART stopped ValueSet
  • Treatment failure ValueSet
  • General care activities recommended ValueSet
  • Preventing and treating coinfections ValueSet
  • Risk factors, comorbidities and coinfections signs and symptoms ValueSet
  • WHO HIV clinical stage condition or symptom ValueSet
  • Clinical stage at start of ART ValueSet
  • Reasons for delayed ART initiation ValueSet
  • Time to start ART ValueSet
  • Reason for HIV viral load test ValueSet
  • Monitoring examinations ValueSet
  • Reason for ARV drug regimen substitution ValueSet
  • ART start type ValueSet
  • Reason for regimen switch ValueSet
  • ART regimen prescribed ValueSet
  • Coinfection status at ART start ValueSet
  • Pregnant and breastfeeding status at ART start ValueSet
  • Medications prescribed ValueSet
  • Medications dispensed ValueSet
  • Type of treatment-limiting toxicity ValueSet
  • Reason(s) for substitution within first-line regimen ValueSet
  • New antiretroviral regimen after substitution within first-line regimen ValueSet
  • New regimen after switch to second-line regimen ValueSet
  • Reason for switch to second-line regimen ValueSet
  • Reason(s) for substitution within second-line regimen ValueSet
  • New regimen(s) after substitution within second-line regimen ValueSet
  • New regimen after switch to third-line regimen ValueSet
  • Reason for switch to third-line regimen ValueSet
  • Reason(s) for substitution within third-line regimen ValueSet
  • New regimen(s) after substitution within third-line regimen ValueSet
  • HIV status of family member ValueSet
  • Other support services ValueSet
  • Facility transferred from ValueSet
  • Type of follow-up appointment ValueSet
  • Reason blood pressure reading not done ValueSet
  • Current medications ValueSet
  • Facility where client first enrolled in HIV care ValueSet
  • Antiretroviral (ARV) drugs received prior to enrolment ValueSet
  • Allergies ValueSet
  • Family planning method used ValueSet
  • Medication status ValueSet
  • Vaccine brand ValueSet
  • Vaccine type ValueSet
  • Vaccination location ValueSet
  • Disease targeted ValueSet
  • Location ARV drugs received prior to enrolment ValueSet
  • Reason immunization was not provided ValueSet
  • ARV drug regimen received prior to enrolment ValueSet
  • Reason malaria prophylaxis not provided ValueSet
  • Existing chronic health conditions ValueSet
  • Cervical cancer primary screening test type ValueSet
  • HPV-DNA cervical cancer screening test result ValueSet
  • VIA cervical cancer screening test result ValueSet
  • Cervical cytology screening test result ValueSet
  • Cervical cancer triage test type ValueSet
  • HPV16/18 test result ValueSet
  • Cervical cancer colposcopy result ValueSet
  • Cervical cancer histopathology result ValueSet
  • Cervical cancer screening outcome ValueSet
  • Cervical cancer diagnosis ValueSet
  • Cervical cancer stage at diagnosis ValueSet
  • Treatment method for cervical precancer lesions ValueSet
  • Invasive cervical cancer treatment method ValueSet
  • Original first-line ART regimen ValueSet
  • Entry point for facility-level testing ValueSet
  • Current ART regimen ValueSet
  • Offer other clinical services ValueSet
  • DSD ART model(s) ValueSet
  • Preferred first-line ART regimen ValueSet
  • Syndrome/STI diagnosed ValueSet
  • Alternative first-line ART regimen ValueSet
  • STI tested for ValueSet
  • First-line ART regimen under special circumstances ValueSet
  • Preferred second-line ART regimen ValueSet
  • Syphilis test result ValueSet
  • Gonorrhoea test result ValueSet
  • Alternative second-line ART regimen ValueSet
  • Type of specimen ValueSet
  • Optimal regimen for transition ValueSet
  • Syphilis test type ValueSet
  • Neisseria gonorrhoeae test type ValueSet
  • Current ART regimen (first-, second-, or third-line) ValueSet
  • Chlamydia trachomatis test type ValueSet
  • Trichomonas vaginalis test type ValueSet
  • Herpes simplex virus (HSV) test type ValueSet
  • Mycoplasma genitalium test type ValueSet
  • STI test result ValueSet
  • Confirmatory syphilis test type ValueSet
  • Confirmatory STI test result ValueSet
  • Staging of liver disease ValueSet
  • WHO functional status ValueSet
  • ART regimen ValueSet
  • Medication/drug ValueSet
  • WHO HIV clinical stage condition or symptom ValueSet
  • TB diagnosis result ValueSet
  • Method of TB diagnosis ValueSet
  • TB treatment history ValueSet
  • TB screening algorithm ValueSet
  • Symptoms of TB ValueSet
  • TB screening result ValueSet
  • TB diagnostic test category ValueSet
  • Maternal HIV test result ValueSet
  • Infant or child exposure to HIV ValueSet
  • Key population member type ValueSet
  • Infant feeding practice ValueSet
  • Type of iron supplement dosage provided ValueSet
  • Maternal HIV status ValueSet
  • Maternal HIV status at first ANC visit ValueSet
  • Maternal syphilis test result ValueSet
  • Signs of substantial risk of HIV infection ValueSet
  • HIV test type ValueSet
  • Past pregnancy complications ValueSet
  • Maternal and child health service visit ValueSet
  • EID sample number ValueSet
  • EID test number ValueSet
  • EID test number 1 test result ValueSet
  • EID test number 2 test result ValueSet
  • Assay number in testing strategy ValueSet
  • Test result of HIV assay 1 ValueSet
  • Test result of HIV assay 2 ValueSet
  • Test result of HIV assay 3 ValueSet
  • Test result of HIV assay 1 repeated ValueSet
  • Test result of syphilis assay 1 ValueSet
  • Test result of syphilis assay 1 repeated ValueSet
  • Infant HIV status ValueSet
  • Final diagnosis of HIV-exposed infant ValueSet
  • HIV-exposed infant reason for unknown final status ValueSet
  • Cause of death of infant ValueSet
  • Blood group and Rh factor ValueSet
  • Asymptomatic bacteriuria (ASB) test result ValueSet
  • Urine protein test result ValueSet
  • Type of hypertensive disorder ValueSet
  • Timing of ART initiation ValueSet
  • Pregnancy outcome ValueSet
  • Delivery mode ValueSet
  • Source of gestational age ValueSet
  • Preterm birth status ValueSet
  • Place of delivery ValueSet
  • Cause of death of mother ValueSet
  • Gender of infant ValueSet
  • HIV viral load specimen type ValueSet
  • HBsAg test result ValueSet
  • Reason Hepatitis B test not conducted ValueSet
  • Hepatitis B diagnosis ValueSet
  • Reason Hepatitis C test not done ValueSet
  • HCV test result ValueSet
  • HCV viral load test result ValueSet
  • Hepatitis C diagnosis ValueSet
  • Syphilis test type ValueSet
  • Reason syphilis test not done ValueSet
  • Syphilis test result ValueSet
  • Syphilis diagnosis ValueSet
  • Reason for follow-up ValueSet
  • Contact method ValueSet
  • Source of information ValueSet
  • Outcome from outreach attempt ValueSet
  • HIV status of partner or contact ValueSet
  • HIV treatment outcome ValueSet
  • Transfer to facility ValueSet
  • Reason(s) for adherence problem ValueSet
  • Reason ART stopped ValueSet
  • Reason for referral ValueSet
  • HIV status of contact ValueSet
  • HIV prevention intervention ValueSet